Recordati | REC - Gross Profit On Sales

Stock Price
44.48
Daily Change
-0.18 -0.40%
Monthly
-7.68%
Yearly
-17.63%
Q1 Forecast
44.07

Recordati reported EUR432.41M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Almirall EUR 429.87M 180.02M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Orion EUR 508.7M 254.5M Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025